Related references
Note: Only part of the references are listed.Botulinum Toxin, Lidocaine, and Dry-Needling Injections in Patients with Myofascial Pain and Headaches
Roberta de Abreu Venancio et al.
CRANIO-THE JOURNAL OF CRANIOMANDIBULAR PRACTICE (2016)
Ultrasound Imaging of Embedded Shrapnel Facilitates Diagnosis and Management of Myofascial Pain Syndrome
Hariharan Shankar et al.
PAIN PRACTICE (2013)
Botulinum Toxin Treatment of Myofascial Pain: A Critical Review of the Literature
Robert Gerwin
CURRENT PAIN AND HEADACHE REPORTS (2012)
Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: A randomized, controlled, double-blind multicenter study
Malin Ernberg et al.
PAIN (2011)
Treatment of Refractory Pain with Botulinum Toxins-An Evidence-Based Review
Bahman Jabbari et al.
PAIN MEDICINE (2011)
Updates on the antinociceptive mechanism hypothesis of botulinum toxin A
K. Roger Aoki et al.
PARKINSONISM & RELATED DISORDERS (2011)
The role of botulinum toxin in management of pain: an evidence-based review
Erisela Qerama et al.
CURRENT OPINION IN ANESTHESIOLOGY (2010)
A Double-Blind, Controlled, Randomized Trial to Evaluate the Efficacy of Botulinum Toxin for the Treatment of Lumbar Myofascial Pain in Humans
Jose De Andres et al.
REGIONAL ANESTHESIA AND PAIN MEDICINE (2010)
The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis
Tony Zhang et al.
INFLAMMOPHARMACOLOGY (2010)
Comparison of 3 Needle Sizes for Trigger Point Injection in Myofascial Pain Syndrome of Upper- and Middle-Trapezius Muscle: A Randomized Controlled Trial
Seung-Hyun Yoon et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2009)
Novel Applications of Ultrasound Technology to Visualize and Characterize Myofascial Trigger Points and Surrounding Soft Tissue
Siddhartha Sikdar et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2009)
Botulinum Toxin A in the Treatment of Chronic Tension-Type Headache With Cervical Myofascial Trigger Points: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
R. Norman Harden et al.
HEADACHE (2009)
Botulinum Neurotoxin-A for Treatment of Refractory Neck Pain: A Randomized, Double-Blind Study
Diana Miller et al.
PAIN MEDICINE (2009)
Trigger Point Injections for Chronic Non-Malignant Musculoskeletal Pain: A Systematic Review
N. Ann Scott et al.
PAIN MEDICINE (2009)
Receptor and substrate interactions of clostridial neurotoxins
Axel T. Brunger et al.
TOXICON (2009)
Therapeutic use of botulinum toxin type a in treating neck and upper-back pain of myofascial origin: A pilot study
Henry L. Lew et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2008)
Mochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points
Jay P. Shah et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2008)
The analgesic effect of botulinum-toxin a on postwhiplash neck pain
Clara Braker et al.
CLINICAL JOURNAL OF PAIN (2008)
Muscle Pain: Mechanisms and Clinical Significance
S. Mense
DEUTSCHES ARZTEBLATT INTERNATIONAL (2008)
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
M. Naumann et al.
NEUROLOGY (2008)
Botulinum neurotoxins in the treatment of refractory pain
Bahman Jabbari
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Evidence for the Use of Botulinum Toxin in the Chronic Pain Setting—A Review of the Literature
Louise C. Jeynes et al.
Pain Practice (2008)
Botulinum toxin A for myofascial trigger point injection: A qualitative systematic review
Kok-Yuen Ho et al.
EUROPEAN JOURNAL OF PAIN (2007)
Glia as the bad guys: Implications for improving clinical pain control and the clinical utility of opioids
Linda R. Watkins et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Variability of criteria used to diagnose myofascial trigger point pain syndrome - Evidence from a review of the literature
Elizabeth A. Tough et al.
CLINICAL JOURNAL OF PAIN (2007)
The structure and mode of action of different botulinum toxins
J. O. Dolly et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport®) for the relief of upper back myofascial pain syndrome:: Results from a randomized double-blind placebo-controlled multicentre study
Hartmut Goebel et al.
PAIN (2006)
A double-blind, controlled study of botulinum toxin A in chronic myofascial pain
E. Qerama et al.
NEUROLOGY (2006)
Systematic review: can botulinum toxin be recommended as treatment for pain in myofascial syndrome?
Claudia Alejandra Pereda et al.
REUMATOLOGIA CLINICA (2006)
The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization
Parisa Gazerani et al.
PAIN (2006)
Treatment of refractory, chronic low back pain with botulinum neurotoxin A: An open-label, pilot study
B Jabbari et al.
PAIN MEDICINE (2006)
A second SNARE role for exocytic SNAP25 in endosome fusion
Y Aikawa et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
The effect of small doses of botulinum toxin A on neck-shoulder myofascial pain syndrome: A double-blind, randomized, and controlled crossover trial
T Ojala et al.
CLINICAL JOURNAL OF PAIN (2006)
An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle
JP Shah et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: A randomised double blind crossover study
CL Graboski et al.
PAIN (2005)
Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome
A Kamanli et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A
KR Aoki
NEUROTOXICOLOGY (2005)
Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A
FM Ferrante et al.
ANESTHESIOLOGY (2005)
Botulinum toxin type B in piriformis syndrome
AM Lang
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2004)
Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction
DG Simons
JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY (2004)
Use of botulinum toxin in the treatment of chronic myofascial pain
J De Andres et al.
CLINICAL JOURNAL OF PAIN (2003)
BOTOX and physical therapy in the treatment of piriformis syndrome
LM Fishman et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2002)
Immediate effects of various physical therapeutic modalities on cervical myofascial pain and trigger-point sensitivity
CR Hou et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2002)
Effect of botulinum toxin on endplate noise in myofascial trigger spots of rabbit skeletal muscle
TS Kuan et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2002)
Endplate potentials are common to midfiber myofacial trigger points
DG Simons et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2002)
The role of zinc binding in the biological activity of botulinum toxin
LL Simpson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Botulinum toxin A and chronic low back pain - A randomized, double-blind study
L Foster et al.
NEUROLOGY (2001)
A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm
M Porta
PAIN (2000)
Share Paper
